134. Dx to Rx – Transitioning from Diagnostics to Pharma
My guest today is Namratha Sastry, PhD, Associate Director of Field Medical Affairs, Oncology at Regeneron and we discuss the transition from diagnostics and Pharma "The views and opinions expressed in the following presentation are those of the individual presenter and should not be attributed to any organization with which the presenter is employed or affiliated." Namratha shares…. 👉 The differences and similarities between Dx MSLs and Rx MSLs differences in terms of regulation between the two types of companies 👉 How KOL interactions are handled in a Dx role vs Pharma 👉 What the relationship is like with commercial in a diagnostics MSL role 👉 What the relationship is like with commercial in a diagnostics MSL role The podcast is available through the links below: ️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn ️ ️ 〰️ Apple: https://lnkd.in/egSthAz ️ ️ 〰️ Stitcher: https://lnkd.in/eqB-2wb ️ ️ 〰️ Youtube: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA Follow MSL Talk on: Instagram: https://www.instagram.com/msl_talk_podcast/ MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical